Primary FDA-Approved Indications
Reserve minocycline for adolescents requiring systemic acne therapy or culture-proven infections responsive to tetracyclines. Consider antimicrobial stewardship—many infections have safer or narrower alternatives.
Moderate to severe inflammatory acne vulgaris
FDA ApprovedAlways combine with topical benzoyl peroxide/retinoid to reduce resistance; reassess need every 3 months.